findmyKOL

Ang Chen, MD

Basic profile

University of North Carolina at Greensboro

ORCIDNPI
RegionFlagstaff, AZ · WestSpecialtyNephrologyFocusNephrology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ang Chen is a Nephrology physician affiliated with University of North Carolina at Greensboro. OpenAlex indexes 141 publications with 3,744 citations (h-index 35).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
141publications

Distinct works indexed by OpenAlex, matched via ORCID.

3,744citations

Total citations across indexed works.

35h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
15companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2201 N Vickey St Ste 110
Flagstaff, AZ 860046126

Telephone

928-213-9460

Registry record last updated 29 Oct 2019.

View the NPPES registry record

Industry payments

15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    50.7%
    Calcium channel blocker15.7%
    Amlodipine Besylate62%Nifedipine Er38%
    Part D<11 patients
    ACE inhibitor9.2%
    Lisinopril100%
    Part D20 patients

    + 6 more classes in this area

  • Other

    21.3%
    Phosphate Binder14.2%
    Sevelamer Carbonate100%
    Part D28 patients
    Drugs for treatment of hyperkalemia and hyperphosphatemia7.1%
    Velphoro100%
    Part D17 patients
  • Musculoskeletal

    12.2%
    Xanthine oxidase inhibitor12.2%
    Allopurinol100%
    Part D29 patients
Where care is delivered (Part B)27% facility · 73% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”